Krystal Biotech Stock
Krystal Biotech Stock
The price for the Krystal Biotech stock decreased slightly today. Compared to yesterday there is a change of -€0.650 (-0.430%).
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Krystal Biotech.
As a result the target price of 173 € shows a slightly positive potential of 14.76% compared to the current price of 150.75 € for Krystal Biotech.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Krystal Biotech stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Krystal Biotech in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Krystal Biotech vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Krystal Biotech | -0.430% | -5.405% | -2.949% | 85.767% | 30.517% | - | - |
Ardelyx Inc. | 3.750% | -5.482% | -15.972% | 32.578% | 3.218% | -12.905% | - |
Salarius Pharmaceuticals Inc. | 4.250% | -0.935% | -18.462% | -68.120% | -23.604% | -98.261% | -99.994% |
Brainstorm Cell | 1.170% | -0.896% | -1.485% | -81.710% | 114.440% | -80.717% | - |
Comments
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Show more
Ratings data for KRYS provided by MarketBeat
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
Show more
Ratings data for KRYS provided by MarketBeat
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KRYS provided by MarketBeat